1. Introduction {#s0005}
===============

Impulsivity is a multifaceted construct and is typified by a premature, poorly controlled, delay averse response pattern where the consequences of acts are poorly considered ([@bib26], [@bib71], [@bib74]). It has been investigated as a potential correlate of both Attention-Deficit/Hyperactivity Disorder (ADHD) and Obsessive-Compulsive Disorder (OCD), disorders which affect around 3--8% and 1--3% of children respectively, as well as around 4% (ADHD) and 2% (OCD) of adults ([@bib5], [@bib75]). A role for impulsivity has been hypothesised in both disorders. This is despite their very distinct symptom profiles, with ADHD defined by age-inappropriate problems with inattention, impulsivity and hyperactivity, and OCD defined by obsessions, i.e. recurrent and intrusive thoughts (e.g., on themes of contamination, checking, orderliness and symmetry), and compulsions, i.e. repetitive, ego-dystonic and time-consuming behavioural and mental rituals (e.g., repetitive washing or checking) ([@bib1]).

Impulsivity is a core feature of ADHD, which is particularly prevalent during childhood and adolescence ([@bib1]). In OCD, increased self-reported impulsivity is associated with poorer treatment outcomes ([@bib39]). Compulsivity and impulsivity are traditionally situated at opposing ends of a compulsivity-impulsivity spectrum, with OCD considered the archetypal disorder of compulsivity ([@bib26], [@bib69]). However, recent research questions this model and suggests that compulsivity and impulsivity may in fact co-exist in OCD ([@bib26], [@bib32], [@bib39], [@bib82]). In particular, impulsivity may underlie a tendency to perform OCD behaviours in order to bring about an initially rewarding outcome (i.e., relieve anxiety) despite their negative long-term consequences ([@bib27], [@bib32]).

To date, most neuroimaging studies of impulsivity in ADHD and OCD have focused on tasks involving motor impulsivity, i.e. the poor ability to inhibit inappropriate prepotent responses during response inhibition paradigms ([@bib4], [@bib43], [@bib53], [@bib72], [@bib91], [@bib93]). Recent fMRI studies and a large meta-analysis have provided evidence for disorder-specific fronto-insula-striatal activation abnormalities in the two disorders, with lateral inferior prefrontal underactivation being disorder-specific to ADHD ([@bib53], [@bib54], [@bib72], [@bib73]), and medial frontal dysfunction being disorder-specific to OCD ([@bib53], [@bib54]). However, impulsivity is a multifaceted construct ([@bib26]), and much less research has examined the neural basis of other impulsivity domains such as choice impulsivity, defined as the tendency to prefer smaller immediate rewards over larger delayed rewards, which is also a feature of ADHD and OCD ([@bib51], [@bib58], [@bib82]).

Choice impulsivity is typically measured in temporal discounting (TD) tasks ([@bib21], [@bib26], [@bib34]), during which participants are provided with a series of choices between small immediate rewards and larger rewards available after a hypothetical delay, typically ranging from weeks to years. TD refers to the finding that the subjective values of rewards available after a delay decrease as a function of the length of the delay ([@bib21], [@bib34]). In studies incorporating adjusting-amount procedures, adjustments of the immediate reward are performed according to the individual participant\'s previous choices using an online algorithm, such that the range of options is narrowed around the point where the subjective value of the immediate reward is equal to that of the fixed delayed reward (the indifference point) ([@bib13], [@bib21], [@bib67]). Indifference points across different delay lengths are used to produce a discounting curve, which is typically hyperbolic (i.e., as delay periods become longer, the rate at which reward values are declined decreases more drastically) ([@bib59]). The steepness of discounting curves varies widely between individuals, and steeper discounting indicates more impulsive choices ([@bib34], [@bib59]). The task measures several cognitive functions, such as the inhibition of the immediate thrill of the reward, the sensitivity of an individual to the varying real or hypothetical delay of time in units of reward (delay aversion), temporal foresight to understand the future gain of the delayed choice, as well as inter-temporal decision making and reward evaluation with respect to its delay ([@bib21], [@bib34], [@bib51], [@bib74]).

Performance during TD tasks relies on two main brain networks ([@bib21], [@bib36], [@bib59]). The first of these involves the ventral striatum, ventromedial prefrontal cortex/orbitofrontal cortex (VMPFC, OFC), and posterior cingulate cortex (PCC), i.e. paralimbic regions involved in processing rewards and motivation ([@bib21], [@bib59]). The second network involves inferior, rostrolateral and dorsolateral prefrontal cortex (IFG, RLPFC, DLPFC), anterior insula (AI), dorsal striatum, parietal lobe and cerebellum, i.e. regions involved in executive functions such as inhibitory control ([@bib38], [@bib88]), working memory ([@bib49], [@bib88]), planning ([@bib85]), prospection ([@bib11]), reappraisal ([@bib23], [@bib29], [@bib41], [@bib86]), time estimation ([@bib37], [@bib51], [@bib74]) and attentional control ([@bib38], [@bib73]), processes which are important for making farsighted delayed choices ([@bib21], [@bib74], [@bib88]). ADHD patients have shown steeper discounting rates than controls in TD tasks and reduced activation in executive function regions including IFG, AI and dorsal striatum during delayed choices ([@bib13], [@bib74]), as well as altered correlations between IFG, temporal lobe, AI, supplementary motor area and cerebellum activation and TD discounting rates relative to controls ([@bib18]). In adult ADHD, reduced activation has been reported in DLPFC, striatal, parietal and cerebellar regions during TD ([@bib56], [@bib60]).

Impulsive decision making is also a feature of OCD ([@bib17], [@bib39], [@bib82]), including during TD ([@bib82]). Previous research has established the importance of VMPFC/OFC and striatal regions in OCD ([@bib45], [@bib62], [@bib63], [@bib77]), which are reliably activated during symptom provocation ([@bib70]), dysfunctional during cognitive and reward tasks ([@bib57], [@bib66]), and highly relevant to TD ([@bib21], [@bib59]). In line with this, we recently showed that adolescents with OCD had altered activation in VMPFC/OFC and left caudate during TD, as well as in DLPFC, IFG, AI, parietal lobes and cerebellum ([@bib15]).

It is not clear to what extent the underlying brain mechanisms of TD differ or are shared between disorders as no published studies have directly compared ADHD and OCD patients during TD using fMRI. Shared neural dysfunction would lend credence to the idea that impulsive decision making in ADHD and OCD is a shared transdiagnostic mechanism, whereas disorder-specific patterns of functional abnormalities would suggest that shared decision making impairments are similar phenocopies associated with distinct underlying mechanisms ([@bib69]).

The aim of this study was therefore to conduct the first direct comparison of the neurofunctional substrates of TD in ADHD and OCD patients using fMRI. Behaviourally, we anticipated that both patient groups would show steeper discounting relative to controls ([@bib58], [@bib82]). In the brain, we hypothesised shared underactivation in both disorders relative to controls in striatal, DLPFC and cerebellar regions previously implicated in ADHD ([@bib13], [@bib38], [@bib53]) and OCD ([@bib14], [@bib15], [@bib16]; [@bib53]; [@bib72], [@bib73]). We, however, hypothesised more prominent or disorder-specific abnormalities in OCD patients in VMPFC/OFC ([@bib15], [@bib45], [@bib53], [@bib54]), and larger or disorder-specific underactivation in IFG in ADHD patients ([@bib51], [@bib53], [@bib54], [@bib74], [@bib72]). Data have been published in other forms elsewhere, although in this paper we provide the novel comparison between controls, patients with ADHD and patients with OCD ([@bib13], [@bib15], [@bib18], [@bib21], [@bib74]).

2. Methods {#s0010}
==========

2.1. Participants {#s0015}
-----------------

Sixty-six (26 ADHD, 20 OCD, 20 controls) right handed ([@bib55]) male adolescents participated, aged between 12--18, and with an IQ\>70 as measured by the Wechsler Abbreviated Scale of Intelligence-Revised (WASI-R) short form ([@bib87]). ADHD boys were recruited from local child and adolescent mental health services (CAMHS) and met DSM-IV criteria for inattentive/hyperactive-impulsive combined subtype, as assessed using the standardized Maudsley diagnostic interview ([@bib30]), and scored above clinical cut-off on the Conner\'s Parent Rating Scale-Revised (CPRS-R) ([@bib22]) and the inattention/hyperactivity scale of the parent Strength and Difficulty Questionnaire (SDQ) ([@bib31]). A consultant psychiatrist excluded comorbidity with other disorders (except conduct disorder), including OCD. Twelve ADHD boys were medication naïve. Fourteen ADHD boys were receiving psychostimulant medication and underwent a 48 h washout period prior to scanning. OCD boys were recruited from a national specialist clinic for child and adolescent OCD and local CAMHS and had clinical diagnoses of OCD, assessed according to the 10th edition of the International Classification of Diseases (ICD-10) criteria and the Children\'s Yale-Brown Obsessive Compulsive Scale ([@bib78]). Absence of comorbidity, including comorbid ADHD, was confirmed by a consultant psychiatrist. Sixteen OCD boys were medication naïve. Four were being treated with selective serotonin re-uptake inhibitor (SSRI) medication. One of these four patients was receiving risperidone as an augmentation treatment. Control participants had no psychiatric diagnoses, and were recruited using local advertising. Only boys were studied due to the preponderance of males in adolescent ADHD and OCD populations, and to achieve greater homogeneity across participants and groups ([@bib28], [@bib89]). Exclusion criteria included comorbid psychiatric disorders, medical disorders affecting brain development, drug/alcohol dependency, head injury, abnormal brain structural MRI findings and MRI contraindications.

Ethical approval was obtained from the local Research Ethics Committee (05/Q0706/275), and the study was conducted in accordance with the Declaration of Helsinki. Study details were explained to both child and guardian. Written informed consent was obtained for all participants.

2.2. Temporal discounting fMRI task {#s0020}
-----------------------------------

In each trial of the TD task ([@bib13], [@bib18], [@bib21], [@bib74]) participants are presented with the choice of an amount of money (£100) available after a delay or a smaller amount of money available immediately (0--£100). Delay lengths are one week, one month and one year. For each participant, an algorithm is used to find values for the immediate option which are treated subjectively as equivalent to the larger delayed option for each delay length, thus ensuring each participant makes an equal number of immediate and delayed choices ([@bib13], [@bib18], [@bib21], [@bib74]). Immediate options are presented on the left side of the screen and are selected by pressing a button placed under the right index finger. Delayed options are presented on the right side of the screen and are selected with the right middle finger. Each trial lasts for 4 s, separated by blank screen interval of at least 8 s (depending on the participant\'s reaction time), which acts as an implicit baseline in the fMRI analysis (inter-trial-interval: 12 s). Participants complete twenty trials for each delay length ([Fig. 1](#f0005){ref-type="fig"}.). All participants completed an initial practice session of the task within a "mock scanner". Task length is 12 min.Fig. 1*Schematic representation of the temporal discounting (TD) task.* In the TD task, participants choose between an amount of money (£100) available after a delay of one week, one month and one year or a smaller amount of money available immediately (0--£100). For each participant, an algorithm is used to find values for the immediate option which are subjectively equivalent to the larger delayed option for each delay length, which ensures that participants make an equal number of immediate and delayed choices. Immediate options are presented on the left side of the screen and are selected by pressing a button placed under the right index finger. Delayed options are presented on the right side of the screen and are selected with the right middle finger. Each trial lasts for 4 s, separated by blank screen interval of at least 8 s (depending on the participant\'s reaction time) (inter-trial-interval: 12 s).Fig. 1

2.3. Analysis of performance data {#s0025}
---------------------------------

First, indifference points were calculated for each participant at each delay length. The indifference point as defined here is the midpoint value between the lowest selected immediate reward and the next highest offered reward value, and represents the subjective value of £100 after the specified delay. The subjective value of reward on the TD task can be described using a hyperbolic decay function, and estimated using the equation V = A/(1 + *k*D), where V is the subjective value of a reward, A is size of the reward, D is the delay until reward receipt, and *k* is a constant which characterizes an individual\'s rate of discounting, and which is calculated by fitting a hyperbolic function to the indifference values for every delay ([@bib21], [@bib68]). Larger *k* values indicate steeper discounting ([@bib68]). A three-way ANCOVA, controlling for non-significant differences in age, was performed between groups with *k* as the dependent measure to test for group differences in TD performance. To aid interpretation of potential group differences in *k,* indifference points for week, month and year delays were subjected to separate three-way ANCOVAs. Potential differences in reaction times were examined using a 2 (immediate and delayed choices) × 3 (ADHD, OCD & control groups) ANCOVA. We anticipated group differences in IQ, since ADHD is associated with low IQ ([@bib8]). IQ was not covaried in the first instance as covarying for differences between groups that were not randomly selected violates ANCOVA assumptions ([@bib47]). However, supplementary analyses were performed covarying for IQ to test potential confounds.

2.4. fMRI image acquisition {#s0030}
---------------------------

The fMRI images were acquired at King\'s College London, Institute of Psychiatry\'s Centre for Neuroimaging Sciences on a 3 T General Electric Signa Horizon HDx MRI scanner (GE Healthcare, UK). Details on scanning parameters are given in the [Supplement](#s0095){ref-type="sec"}.

2.5. fMRI data analysis methods {#s0035}
-------------------------------

Data were analysed using the non-parametric XBAM software package ([@bib7]). XBAM\'s non-parametric approach overcomes many of the issues associated with parametric software packages (e.g., poor control of FWE-corrected false positive cluster-wise inference rates) ([@bib10], [@bib25]). Details of individual and group-level analyses are described elsewhere ([@bib20]) and in the [Supplement](#s0095){ref-type="sec"}.

In short, time-series analysis of individual subject activation was performed with wavelet-based resampling ([@bib9]). We first convolved the task epoch of each event of interest with two Poisson model functions (4 s and 8 s delays). Using rigid-body and affine transformation, individual maps were registered into Talairach space ([@bib84]). Group maps were then produced for each experimental condition, and hypothesis testing was performed using cluster-level analysis, shown to give excellent cluster-wise type-I error control ([@bib9]). Time-series permutation was used to compute the distribution of the statistic of interest under the null hypothesis. The voxel-level threshold was set to *p*\<0.05 to give maximum sensitivity and to avoid type-II error ([@bib10]). Then, a cluster-mass threshold was computed from the distribution of cluster masses in the wavelet-permuted data such that the final expected number of type-I error clusters under the null hypothesis was less than one per whole brain.

For comparisons between groups, a one-way ANCOVA was conducted with group as factor and head displacement in Euclidian 3-D space and age as covariates ([@bib9], [@bib10]). Age was included as a covariate given established maturation effects on performance and neural function during TD ([@bib21]). For the between-group comparisons of the delayed-immediate contrast, less than one false activated cluster was expected at *p*\<0.05 for voxel and *p*\<0.027 for cluster comparisons. Analyses were repeated with IQ and *k* as additional covariates, to rule out the possibility that group differences resulted from differences in IQ or task performance.

In order to interpret the group differences in brain activation from the between-group ANCOVA, statistical measures of BOLD response (SSQ) for each participant were extracted from significant clusters, plotted, and subjected to pairwise (ADHD vs OCD, ADHD vs controls, OCD vs controls) *post-hoc t* -tests (corrected for multiple comparisons for three groups using the least significance difference method). Follow-up analyses were performed between medicated and unmedicated patients with ADHD as well as between controls, unmedicated ADHD and unmedicated OCD using these extracted BOLD responses.

3. Results {#s0040}
==========

3.1. Participant characteristics {#s0045}
--------------------------------

There were no significant group differences in age, but IQ was significantly lower in ADHD ([Table 1](#t0005){ref-type="table"}).Table 1Participant characteristics.Table 1**ControlsADHDOCDSig.***N*202620--Medicated/unmedicatedN/A14/124/16Age15.3 (1.78)14.89 (1.71)15.75 (1.43)*F*(2,63)=1.99, *p*=0.15IQ118.9 (11.99)102.57 (12.54)117.7 (13.36)*F*(2,63)=12.63, *p*\<0.001C,OCD\>ADHDSDQ Hyperactivity/Inattention1.95 (1.58)8.96 (1.1)4.4 (3.03)*F*(2,62)=71.16, *p*\<0.001ADHD\>OCD\>CSDQ Emotional0.32 (0.58)3.62 (2.87)4.35 (2.58)*F*(2,62)=16.61, *p*\<0.001ADHD,OCD\>CSDQ Conduct0.74 (1.1)4.73 (2.47)1.85 (1.53)*F*(2,62)=27.54, *p*\<0.001ADHD\>OCD,CSDQ Peer1.32 (3.07)3.2 (2.33)1.85 (1.90)*F*(2,62)=4.38, *p*=0.02C,OCD\>ADHDSDQ Prosocial9.05 (1.78)5.92 (2.51)7.65 (2.58)*F*(2,62)=11.03, *p*\<0.001ADHD\>OCD,CCY-BOCS......22.32 (5.97)Conner\'s T...81.12 (7.55)...K mean0.016 (0.013)0.046 (0.042)0.027 (0.031)*F*(2,62)=4.61, *p*=0.01ADHD\>C,OCDIP week89.1 (8.72)79.31 (18.07)81.65 (16.37)*F*(2,62)=2.33, *p*=0.11IP month74.4 (13.69)52.12 (28.84)73.30 (17.97)*F*(2,62)=7.36, *p*\<0.001C,OCD\>ADHDIP year38.6 (23.93)39.23 (26.42)40.75 (25.25)F(2,62)=0.04, p=0.96Immediate RT (ms)2130.39 (596.59)2301.14 (625.03)2239.26 (445.1)*F*(2,62)=0.65, *p*=0.52Delayed RT (ms)2208.88 (612.48)2310.34 (620.8)2317.82 (418.44)*F*(2,62)=0.23, *p*=0.8[^2]

3.2. Performance data {#s0050}
---------------------

ANCOVA showed a significant between-group difference in *k* (*F*(2,62)=4.49, *p*=0.02) that was driven by steeper discounting in ADHD relative to control boys (*p=*0.003) but not relative to OCD boys (*p=*0.12) ([Table 1](#t0005){ref-type="table"}). Significant group differences were found in mean indifference points for one month delays (*F*(2,62)=7.36, *p*\<0.001), which were smaller in ADHD relative to healthy controls (*p*=0.001) and patients with OCD (*p*=0.002), who did not differ from each other (*p*=0.89). This finding survived after covarying IQ (*F*(2,61)=3.44, *p*=0.04). ANCOVA comparing groups for indifference points for one week (*F*(2,62)=2.33, *p*=0.11) and one year (*F*(2,62)=0.04, *p*=0.96) were not significant. There was a trend for participants to be slower when making delayed relative to immediate choices (*F*(1,62)=3.56, *p*=0.06). However, the group by choice interaction was not significant (*F*(2,62)=0.79, *p*=0.46). Reaction times did not differ between groups for either immediate (*F*(2,62)=0.65, *p*=0.52) or delayed (*F*(2,62)=0.23, *p*=0.8) decisions. Findings remained unchanged after controlling for IQ, except that the ANCOVA for group differences in *k* remained significant only at trend level (*F*(2,61)=2.99, *p=*0.06) ([Table 1](#t0005){ref-type="table"}).

3.3. fMRI data {#s0055}
--------------

### 3.3.1. Movement {#s0060}

There were no group differences in median displacement of x, y, z rotation and translation parameters (*F*(2,63)=1.6, *p*=0.1).

### 3.3.2. Group brain activation maps for delayed versus immediate choices {#s0065}

Within-group findings for delayed-immediate contrast are presented in the [Supplement](#s0095){ref-type="sec"}.

### 3.3.3. Between-group differences {#s0070}

Whole-brain three-group ANCOVA analysis (controlling for age and motion) with follow-up *post-hoc t* -tests (corrected for multiple comparisons for three groups using least significant differences method) revealed that patients shared underactivation relative to controls in right IFG/AI/caudate (ADHD, *p*=0.02; OCD, *p*=0.006), right thalamus (ADHD, *p*=0.02; OCD, *p*=0.01) and bilateral occipital lobe/cerebellum (ADHD, *p*=0.003; OCD, *p*\<0.001) during delayed relative to immediate trials, as well as left superior/middle temporal/supramarginal gyrus/fusiform gyrus (ADHD, *p*=0.001; OCD, *p*=0.003) and right postcentral/superior temporal/supramarginal gyrus/posterior insula (ADHD, *p*=0.001; OCD, *p*\<0.001) to immediate relative to delayed trials. OCD patients alone showed significantly reduced activation in right OFC (*p*=0.006) and RLPFC/DLPFC (*p*=0.001) relative to controls ([Table 2](#t0010){ref-type="table"} and [Fig. 2](#f0010){ref-type="fig"}.). All group difference clusters remained significant after controlling for IQ and *k* using whole-brain ANCOVA. Follow-up *t*-tests on extracted statistical BOLD activation in group difference clusters performed between medicated and unmedicated ADHD patients showed a significant difference in left temporal/parietal/occipital lobe activation (*p*=0.046), which was more active during immediate choices in medicated patients. In the unmedicated subgroup analysis on extracted BOLD activation, the thalamus cluster no longer differed between ADHD and controls (*p*=0.12) and the right AI/IFG/caudate cluster differed only at a non-significant trend (*p*=0.06), presumably reflecting reduced power. All other group difference clusters remained significant. There were no significant correlations between CY-BOCS scores and brain activation in the group difference clusters in the OCD patients, or between SDQ inattention/hyperactivity scale or CPRS-R scores and brain activation in ADHD patients. There was a significant positive correlation between thalamus activation to delayed choices and *k* (*r*(26)=0.389, *p*=0.049) in ADHD patients, although this correlation did not survive correction for multiple comparisons ([@bib3]). There were no correlations between *k* and brain activation in OCD patients or healthy controls.Fig. 2*ANCOVA results for the between-group differences in brain activation for contrast comparing delayed and immediate choices.* (A) Axial slices for the group activation maps for the three groups with a voxel threshold of *p*\<0.05 and a cluster threshold of *p*\<0.027. Red indicates significant between-group differences in activation for the delayed versus immediate choice contrast. Talairach z-coordinates are indicated for slice distance (in mm) from the intercommissural line. The right side of the brain corresponds to the right side of the image. (B) Bar chart showing mean SSQ for each group in each cluster. Controls = orange, ADHD = purple, OCD = green.Fig. 2Table 2ANCOVA differences in brain activation between adolescents with ADHD and OCD and healthy comparison adolescents.Table 2**Brain regions of activationBATAL COORDVoxelsCluster*****p*****-valueDelay\>ImmediateControls \> OCD**R OFC1133,56,−18480.009R RLPFC10/918,67,20150.001R RLPFC/DLPFC46/1029,56,26600.001**Controls \>ADHD,OCD**R IFG/DLPFC45/4633,44,41050.003R AI/IFG/caudate13/4529,30,9780.015R thalamus11,−11,15270.01L & R cerebellum/occipital lobe17/18/19−29,−96,−77600.004**Immediate\>DelayControls \>ADHD,OCD**R precentral/postcentral/posterior insula/SMG/STL/ MTL4/3/2/13/40/22/41/42/4354,−15,263320.01L STL/MTL/SMG/occipital lobe37/21/22/42/39/17/19−51,−56, 92320.02[^3]

4. Discussion {#s0075}
=============

This fMRI study investigated potentially shared and disorder-specific neurofunctional abnormalities in paediatric ADHD and OCD during TD. The findings show that patient groups relative to controls, shared underactivation in key regions of self-control and temporal foresight ([@bib51], [@bib74]), including right IFG, DLPFC, AI, dorsal striatum and bilateral cerebellum during delayed choices. Only OCD patients showed underactivation during delayed choices relative to controls in a right OFC region responsible for goal-directed reward evaluation ([@bib21], [@bib36]) and in a RLPFC region shown to mediate prospection and planning ([@bib11], [@bib85]). The findings suggest that key mechanisms associated with adaptive reward-related decision making and temporal foresight during TD are impaired in both disorders, while OFC and RLPFC regions are exclusively impaired in OCD.

During TD, IFG, DLPFC, AI, striatum and cerebellum are typically recruited more during the selection of larger delayed than immediate rewards ([@bib21], [@bib36], [@bib74]). These regions are also activated when participants consider the negative long-term consequences of unhealthy foods ([@bib35]), smoking cigarettes ([@bib41]), and illegal drug use ([@bib86]), suggesting a key role in self-control and temporal foresight ([@bib13], [@bib74]). Findings of decreased activation in these regions extend previous findings in ADHD during TD ([@bib56], [@bib74]), by showing that deficits are shared with patients with OCD during this task. Interestingly, we have previously shown that IFG underactivation is disorder-specific in ADHD relative to OCD during inhibitory and attentional control ([@bib53], [@bib54], [@bib72]). Current findings are in line with suggestions that inhibitory control and TD are mediated by neuroanatomically overlapping but functionally dissociable fronto-striatal neural circuits ([@bib26]), and suggest that IFG underactivation in ADHD relative to OCD is task-specific to the contexts of inhibitory and attentional control, but not the context of TD.

Findings of largely shared dysfunction in right IFG, DLPFC, AI, dorsal striatum and cerebellar regions during delayed choices in ADHD and OCD suggest that TD taps into a shared underlying transdiagnostic mechanism ([@bib26]). A further implication of these findings is that shared neural deficits may potentially be normalised using the same psychological or psychopharmacological manipulation across both disorders. For instance, we recently reported that TD performance was normalised in ADHD patients relative to controls following an acute dose of the SSRI fluoxetine. This was also associated with the up-regulation of activation in right IFG, AI, and striatum, regions that we found to be underactive in ADHD and OCD in the current study ([@bib13]). SSRIs including fluoxetine are first line treatment in OCD, and therefore it may be interesting to investigate whether shared underactivation in right hemisphere fronto-insula-striatal regions respond similarly to pharmacological manipulation across disorders.

Only OCD patients showed significantly reduced activation in right OFC during delayed choices relative to controls. The OFC is a key region for representing reward values ([@bib36]), and receives signalling from both striato-limbic regions which process low-level reward properties and from DLPFC regions involved in temporal foresight and self-control, integrating both representations into a goal-directed reward valuation in order to guide long-sighted decision making ([@bib21], [@bib36]). Adults with OCD show reduced DLPFC and OFC recruitment during affective reversal ([@bib65], [@bib66]), suggesting that in OCD patients, alterations within this brain network may underlie the perseverative performance of undesired, goal-irrelevant behaviours due to a failure in flexibly updating reward associations ([@bib66]). Findings of reduced OFC in OCD is in line with predominantly orbito-striatal accounts of the disorder ([@bib45], [@bib53]), and extends these by implicating OFC dysfunction in choice impulsivity in OCD.

In RLPFC, controls showed greater activation during delayed choices while OCD patients showed greater activation during immediate choices. RLPFC has been implicated in episodic prospection ([@bib11]), planning ([@bib85]), counterfactual thinking ([@bib6]), and representing abstract, temporally extended goals ([@bib2]), i.e. in processes involved in comparing competing options and considering their long-term outcomes. Results parallel our meta-analytic finding of disorder-specific increased RLPFC grey matter in paediatric OCD relative to paediatric ADHD ([@bib53]). Also, OCD patients show altered activity in this region during resting state fMRI ([@bib42]) and symptom provocation studies ([@bib70]). Conventional treatments including cognitive behavioural therapy ([@bib92]) and SSRIs ([@bib12]), as well as treatment with deep-brain stimulation ([@bib42]) and repetitive transcranial magnetic stimulation ([@bib48]) modulate RLPFC cortex activity in OCD, and targeting this region (along with adjacent OFC) with neurofeedback training is associated with a decrease in OCD symptoms ([@bib79], [@bib80]). However, the nature of the relationship between RLPFC alterations and OCD is poorly understood ([@bib33]), and the findings of this study suggests that choice impulsivity may represent one mechanism linking established alterations in this region and OCD.

In line with previous research, we found evidence of steeper discounting in ADHD relative to controls ([@bib58]) but unlike a previous study by Sohn and colleagues ([@bib82]), we did not find evidence of impulsive decision making in OCD patients. However, the study by Sohn and colleagues used a far larger sample size. Owing to the focus on more sensitive neural outcomes, the current study may have been underpowered to detect significant performance differences in the OCD group. It is interesting to note that significant abnormalities in brain functioning in the OCD sample in the current study are seen in the absence of significant differences in behaviour, and this finding along with a lack of any significant correlations between *k* and brain activation and the fact that differences in brain activation remained after controlling for differences in *k* suggest that there is not a one-to-one relationship between brain activation and choice behaviour during TD. As noted above, lateral prefrontal, orbitofrontal, insular and striatal regions are associated with a number of cognitive processes which may be important for TD performance, and these regions have been found to be underactive in patients with OCD during reversal learning, attentional and inhibitory control, and reappraisal tasks ([@bib24], [@bib53], [@bib54], [@bib66], [@bib72], [@bib73]). Findings may suggest a failure to appropriately recruit networks supporting these cognitive processes, which nonetheless was not enough to impact TD performance in OCD significantly. Findings of reduced activation in the absence of impaired performance are in line with previous work in paediatric OCD ([@bib15], [@bib16], [@bib54], [@bib91]).

Limitations of the study include a lower IQ in the ADHD group, in light of evidence linking IQ to TD performance ([@bib81]). However, lower IQ is typical for the population ([@bib8]) and findings remained significant after covarying for IQ. Second, 54% of ADHD patients were receiving psychostimulant medication which has been associated with increased fronto-striatal activation, suggesting that functional deficits in fronto-striatal systems may have been mitigated by stimulant treatment ([@bib74]). However, significant clusters remained largely unchanged between medicated and unmedicated groups, and remained significant in sub-group comparisons of unmedicated patients. While participants were determined by a consultant psychiatrist to be free of comorbidities after clinical assessment, structured interviews to assess common comorbidities including anxiety, mood, impulse and personality disorders in patients and undiagnosed conditions in controls were not performed. Relatedly, sub-clinical depression and anxiety symptoms were not assessed and were likely higher in both patient groups relative to controls ([@bib44]; [@bib46]). Moreover, we did not assess socio-economic status (SES), and low SES has been reported to increase risk for ADHD and OCD ([@bib40], [@bib76]). This is particularly important given that depression, anxiety and low SES have been associated with steeper discounting as well as structural and functional alterations in fronto-limbic and fronto-striatal brain networks involved in reward processing and self-control ([@bib19], [@bib50], [@bib52], [@bib61], [@bib63], [@bib64], [@bib66], [@bib83], [@bib90]). Future work should aim to match groups on these clinical and demographic variables.

To summarise, the study provides the first comparison of functional abnormalities during TD between ADHD and OCD patients. Both disorders were associated with a common pattern of underactivation in fronto-striatal-insula-cerebellum regions implicated in self-control and temporal foresight during delayed choices, suggesting that choice impulsivity in both disorders may partially represent a shared transdiagnostic mechanism. In addition, we found that OFC and RLPFC were disorder-exclusively underactivated in OCD relative to controls, in line with existing orbito-striatal accounts of OCD, and providing initial evidence for its involvement in choice impulsivity in the disorder.

Financial disclosures {#s0080}
=====================

K.R. has received funding from Lilly for another project and speaker\'s honoraria from Lilly, Shire, Novartis and Medice. C.M. has received funding from Lilly for another project and speaker\'s honoraria from Flynn Pharma. The other authors have no conflict of interests to declare.

Contributions {#s0085}
=============

LJN, COC, KR devised the study. LJN & COC analysed the data. LJN prepared the manuscript. LJN, COC, AC, KC, CM collected data. Included authors provided intellectual input into the final draft of the manuscript.

Appendix A. Supplementary material {#s0095}
==================================

Supplementary material

This study was supported by Grants from the Medical Research Council (MRC GO300155) to Prof. Katya Rubia. Prof. Katya Rubia and Dr. Andy Simmons receive funding from National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) at South London and Maudsley NHS Foundation Trust and King\'s College London. Dr Christina Carlisi was supported by a NIHR BRC PhD studentship. Dr. Anastasia Christakou was supported by a post-doctoral fellowship from Medical Research Council (MRC G0300155). Dr Kaylita Chantiluke and Dr Luke Norman were supported by IOP-MRC excellence Ph.D. studentships from the Institute of Psychiatry, Psychology and Neuroscience, King׳s College London. This paper represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King\'s College London. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.

Supplementary data associated with this article can be found in the online version at [doi:10.1016/j.pscychresns.2017.09.008](http://doi:10.1016/j.pscychresns.2017.09.008){#ir0005}.

[^1]: These authors contributed equally to this work.

[^2]: Abbreviations. ADHD, Attention-Deficit/Hyperactivity Disorder; CY-BOCS, Children\'s Yale-Brown Obsessive-Compulsive Scale; IQ, intelligence quotient; OCD, Obsessive-Compulsive Disorder; SDQ, strengths and difficulties questionnaire.

[^3]: *Abbreviations:* ADHD, Attention-Deficit/Hyperactivity Disorder; AI, anterior insula; BA, Brodmann area; DLPFC, dorsolateral prefrontal cortex; IFG, inferior frontal gyrus; MTL, middle temporal lobe; OCD, Obsessive-Compulsive Disorder; OFC, orbitofrontal cortex; RLPFC, rostrolateral prefrontal cortex; SMG, supramarginal gyrus; STL, superior temporal lobe; TAL COORD, Talairach coordinates.
